Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomised controlled trial
Despite lithium's being the most effective drug for bipolar disorder and in clinical use for decades, we still know very little about its early effects relevant to its mode of action.The Oxford Lithium Trial is a double-blind, randomised, placebo-controlled study of 6-week lithium treatment in...
主要な著者: | Saunders, K, Cipriani, A, Rendell, J, Attenburrow, M, Nelissen, N, Bilderbeck, A, Vasudevan, S, Churchill, G, Goodwin, G, Nobre, A, Harmer, C, Harrison, P, Geddes, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
BioMed Central
2016
|
類似資料
-
Oxford Lithium Trial (OxLith) of the early affective, cognitive, neural and biochemical effects of lithium carbonate in bipolar disorder: study protocol for a randomized controlled trial
著者:: Saunders, K, 等
出版事項: (2016) -
Older patients are eligible for trial of lithium and valproate.
著者:: Rendell, J, 等
出版事項: (2003) -
New trial should clarify lithium use in bipolar disorder.
著者:: Geddes, J, 等
出版事項: (2002) -
Lith6
著者:: Malcolm A. Lyons, 等
出版事項: (2003-09-01) -
The Oxford study of calcium channel antagonism, cognition, mood instability and sleep (OxCaMS): Study protocol for a randomised controlled, experimental medicine study
著者:: Atkinson, L, 等
出版事項: (2019)